A combination of two immunotherapy drugs, ipilimumab and nivolumab, stops or reverses the progression of advanced melanoma – with long term survival rates hitting an all-time high – according to a study presented at the ESMO Congress.
Help Andrea Calderon raise money to support The Institute of Cancer Research (ICR)
You could be our next great discovery. We’re searching for the brightest minds in cancer research. Applications for PhDs are open.
Professor Paul Workman is Harrap Professor of Pharmacology and Therapeutics at The Institute of Cancer Research. He has worked in the field of cancer research…
Scientists have developed a new clinical pathway for testing for the cancer-causing faults in the BRCA gene that could ensure patients get the right treatment…
To mark Rare Cancer Day, Isy Godfrey looks at how we are making progress in this field and speaks with paediatric brain tumour expert Professor…
A pioneering apprenticeship programme at the ICR for aspiring laboratory research technicians has won the Education and Training Award at the UK Pharma Industry Awards.
Help Andrea Calderon raise money to support The Institute of Cancer Research (ICR)
Researchers have examined thousands of genetically defined traits to identify possible causal relationships for eight common cancers.
Alison and Brian set up the Doing It For Daniel Foundation in memory of their son, Daniel, who was diagnosed with an aggressive brain tumour…
Cycling from Venice to Rome to support secondary breast cancer research at The Institute of Cancer Research (ICR)
